FDA: Depo-Provera Labels Must Warn of Meningioma Risk December 22, 2025 Labels for Pfizer’s Depo-Provera contraceptive injection must now warn of the risk of meningioma, a type of brain tumor. The U.S. Food and Drug Administration (FDA) required the label change last week. The warning applies to two injectable forms of the drug, Depo-Provera CI and Depo-Subq Provera 104, which consist of progestin, a synthetic form […] Read More
Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) December 17, 2025 Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal multidistrict litigation consolidating lawsuits alleging that popular GLP-1 receptor agonist drugs caused patients to suffer serious vision injuries, including non-arteritic anterior ischemic optic neuropathy, […] Read More
Federal Court Centralizes Roblox Child Sexual Exploitation Lawsuits Into Multidistrict Litigation December 12, 2025 The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered the centralization of federal lawsuits alleging child sexual exploitation and assault facilitated through the Roblox gaming platform, creating In re: Roblox Corporation Child Sexual Exploitation and Assault Litigation, MDL No. 3166. The litigation will proceed in the Northern District of California before Chief U.S. District […] Read More